1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Future Horizons and Growth Strategies in the UK Nucleic Acid Testing Market 2015: Supplier Shares and Country Forecasts

Highlights

  • Comprehensive 1,122-page market segmentation analysis of the UK NAT market.
  • Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:
                 - Infectious Diseases
                 - Cancer
                 - Forensic Testing
                 - Genetic Diseases
                 - Paternity Testing/HLA Typing
  • Review of testing methodologies and instrumentation technologies.
  • Feature comparison of automated and semiautomated analyzers.
  • Sales and market shares of leading suppliers.
  • Over 60 specific opportunities for NAT instruments, test systems, IT and auxiliary products.
  • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,122 pages and 53 tables

Comprehensive 1,122-page market segmentation analysis of the UK NAT market.
  • Major issues pertaining to the UK NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.

    Table Of Contents

    Future Horizons and Growth Strategies in the UK Nucleic Acid Testing Market 2015: Supplier Shares and Country Forecasts
    Table of Contents
    I. Introduction
    II. Major Product Development Opportunities
    A. Instrumentation
    B. Reagent Kits and Test Systems/panels
    C. Computers, Software and Automation
    D. Auxiliary Products
    III. Design Criteria for Decentralized Testing Products
    IV. Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies For Decentralized Testing
    Markets
    V. Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge And Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    VI. Worldwide Market and Technology Review
    A. DNA Sequencing
    1. Introduction
    2. Sequencing Methods
    3. Autoradiography
    4. The Human Genome Project
    5. Sequencing Automation
    Table of Contents (continued)
    6. Image Scanners
    7. Fluorescent Detection
    8. Gene Profiling
    9. Gene Expression
    10. Polymorphism Screening
    11. Protein Interaction Networks
    B. DNA and RNA Probe Technologies
    1. Basic Principles
    2. Probe Preparation
    3. The DNA Probe Test
    4. Test Formats
    5. Labeling Techniques
    6. Amplification Methods
    C. Detection Technologies

    1. Radioactive Methods
    a. Overview
    b. Major Isotopes
    O P-32
    O S-35
    O H-3
    O I-125
    2. Non-Isotopic Methods
    a. Enzymatic Labels
    b. Chemical Labeling
    O Indirect Chemical Labeling
    O Direct Chemical Labeling
    c. Fluorescence
    d. Chemiluminescence
    e. Electrical Conductivity
    D. Molecular Diagnostic Instrumentation Review

    1. Abbott LCx
    2. Beckman Coulter/Biomek FK
    3. BD Viper System with XTR Technology
    4. BD Innova
    5. Becton Dickinson SDA
    Table of Contents (continued)
    6. bioMerieux NucliSENS easyMAG
    7. bioMerieux NucliSENS easyQ and MiniMAG
    8. Bio-Rad GeneScope
    9. Cepheid GeneXpert
    10. Curetis Unyvero
    11. GenMark Dx eSensor XT-8
    12. Hologic/Gen-Probe Panther
    13. Hologic/Gen-Probe Tigris/DTS
    14. HTG Molecular Edge
    15. Life Technologies QuantStudio Dx
    16. Qiagen QIAsymphony RGQ
    17. Roche Cobas Amplicor
    18. Roche Cobas TaqMan 48
    19. Roche Cobas TaqMan
    20. Roche Cobas TaqMan AmpliPrep
    21. Roche LighCycler 480
    22. Roche Cobas 4800
    23. Roche Cobas s 201
    24. Siemens Versant
    25. Tecan LS Series
    E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
    - Liquid Transportation and Mixing
    - Separation
    - Reaction
    - Detection
    F. Pharmacogenomics
    G. Major Applications
    1. Microbiology/Infectious Diseases
    a. Overview
    b. Major Infectious Diseases
    ° AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT,
    Western Blot, HTLV-I/II
    ° Adenovirus
    ° Aeromonas
    ° Anthrax/Bacillus Anthracis
    Table of Contents (continued)
    ° Arboviruses
    ° Babesiosis
    ° Bacillary Epithelioid Angiomatosis (BEA)
    and Other Bartonella (Rochalimaea)
    ° Blastocystis Hominis
    ° Brucella
    ° Campylobacter
    ° Candida
    ° Chagas Disease
    ° Chancroid
    ° Chlamydia
    ° Clostridium Difficile
    ° Coronaviruses
    ° Coxsackieviruses
    ° Creutzfeldt-Jakob's Disease
    ° Cryptosporidium Parvum
    ° Cyclospora Cayetanensis
    ° Cytomegalovirus
    ° Ebola Virus
    ° E. Coli
    ° EchoVirus
    ° Encephalitis
    ° Enteroviruses
    ° Epstein-Barr Virus
    ° Giardia Lamblia
    ° Gonorrhea
    ° Granuloma Inguinale
    ° Hantavirus
    ° Helicobacter Pylori
    ° Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT,
    Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag,
    HBe Ag, ALT/SGPT
    ° Herpes Simplex Virus
    ° Human Herpes Virus-6 (HHV-6)
    ° Influenza Viruses
    ° Legionella
    ° Lyme Disease
    ° Lymphogranuloma Venereum (LGV)
    ° Malaria
    ° Measles (Rubeola)
    ° Meningitis
    Table of Contents (continued)
    ° Microsporidium
    ° Mononucleosis
    ° Mumps
    ° Mycoplasma
    ° Papillomaviruses
    ° Parvovirus B19
    ° Pneumonia
    ° Polyomaviruses
    ° Pseudomonas Aeruginosa
    ° Rabies
    ° Respiratory Syncytial Virus (RSV)
    ° Rhinoviruses
    ° Rotavirus
    ° Rubella
    ° Salmonellosis
    ° Septicemia
    ° Shigellosis
    ° Staphylococcus Aureus
    ° Streptococci
    ° Syphilis
    ° Toxoplasmosis
    ° Trichomonas Vaginalis
    ° Tuberculosis
    ° Vibrio
    ° West Nile Virus
    ° Yersina
    2. Cancer Testing
    a. Overview
    b. Major Cancer Types
    * Prostate
    * Lung
    * Colon and Rectum
    * Breast
    * Skin
    * Uterine
    * Leukemia
    * Oral
    c. Oncogenes
    O Abl/abl-bcr
    O AIB1
    Table of Contents (continued)
    O BCL-2
    O BRCA1
    O CD44
    O C-fos
    O C-myb
    O C-myc
    O CYP17
    O Erb-B
    O HPC1
    O N-myc
    O P40
    O P51
    O P53
    O PIK3CA
    O PTI-1
    O Ras
    O Reg
    O Sis
    O Src
    3. Genetic Diseases
    a. Overview
    b. Nucleic Acid Amplification
    c. Chromosome Imaging
    d. Genomics Technologies
    e. Proteomics Technologies
    f. Current Pharmacogenomic Tests
    g. Future Pharmacogenomic Testing
    h. Major Diseases
    * Achondroplasia
    * Autosomal Dominant Polycystic Kidney
    Disease
    * Cancer
    * Cosmetogenomics
    * Cystic Fibrosis
    * Down's Syndrome
    * Duchenne and Becker Muscular Dystrophy
    * Factor V (Leiden)
    * Factor IX Deficiency
    * Fragile X Syndrome
    Table of Contents (continued)
    * Heart Disease
    * Hemochomatosis
    * Hemophilia
    * Huntington's Disease
    * Maternal-Fetal Incompatibility
    * Multiple Endocrine Neoplasia
    * Phenylketonuria (PKU)
    * Polycystic Kidney Disease (PKD)
    * Prenatal Screening
    * Retinitis Pigmentosa
    * Retinoblastoma
    * Sickle Cell Anemia
    * Spinal Muscular Atrophy
    * Vitamin B12 Metabolism
    i. Social Issues and Concerns
    4. Forensic Testing
    a. Overview
    b. Multilocus and Single Locus Probes
    * Multilocus Probes
    * Single Locus Probes
    * PCR and RFLP
    c. The FBI
    d. DNA Profile Data Banks
    * U.S.A.
    * U.K.
    e. Judicial Implementation
    f. Major Crime Categories
    g. Factors Contributing to the DNA Probe
    Market Expansion
    * Technology Availability
    * Use of Hair as Evidence
    h. Wildlife Forensics
    5. Paternity Testing/HLA Typing
    6. Other Applications
    a. Disease Susceptibility Testing
    b. Cardiovascular Diseases
    c. Diabetes
    Table of Contents (continued)
    d. Alzheimer's Disease
    e. Periodontal Disease
    f. Plasma Purification
    g. Organ Transplantation
    h. Water Contamination
    i. Other
    H. Competing/complementing
    1. Monoclonal Antibodies/Immunoassays
    2. RNA Probes
    3. Two-Dimensional Electrophoresis
    4. Flow Cytometry
    VII. U.K. Molecular Diagnostics Market
    A. Executive Summary
    B. Business Environment
    C. Market Structure
    D. Market Size, Test Volume and Sales Forecasts,
    Major Supplier Sales and Market Shares
    VIII. Competitive Assessments

    - Abbott
    - Affymetrix
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biokit
    - bioMerieux
    - Bio-Rad
    - Biotest
    - Cepheid
    - CellMark Forenciscs/LabCorp
    - Decode Genetics
    - Diadexus
    - Eiken
    - Elitech Group
    - Enzo
    Table of Contents (continued)
    - Exact Sciences
    - Fujirebio
    - Grifols
    - Hologic/Gen-Probe
    - Illumina
    - Kreatech/Leica
    - Li-Cor Biosciences
    - Monogram Biosciences/LabCorp
    - Myriad Genetics
    - Ortho-Clinical Diagnostics
    - Perkin Elmer/Caliper
    - Proteome Sciences
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - Shimadzu
    - Siemens
    - Sierra Molecular
    - Takara Bio
    - Tecan Group
    - Thermo Fisher
    XIII. Appendix: Major Universities and Research Centers
    Developing Molecular Diagnostic Technologies



    List of Tables
    Major Companies Developing or Marketing AIDS Molecular
    Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Adenovirus
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Bartonella
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Campylobacter
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Candida
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Chlamydia
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Clostridium
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Coronavirus
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Cryptosporidium
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing CMV Molecular
    Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Echovirus Molecular
    Diagnostic and Other Direct Identification Tests


    List of Tables (continued)
    Major Companies Developing or Marketing Enterovirus Molecular
    Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing EBV Molecular
    Diagnostic and Other Direct Identification Tests
    Major Companies Developing or Marketing Giardia
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Gonorrhea
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Hantavirus
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Helicobacter
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Hepatitis
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Herpes
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Influenza
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Legionella
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Lyme
    Disease Molecular Diagnostic and Other Direct
    Identification Tests


    List of Tables (continued)
    Major Companies Developing or Marketing Measles
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Meningitis
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Mononucleosis
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Mumps
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Mycoplasma
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Pneumonia
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing RSV
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Rotavirus
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Rubella
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Salmonella
    Molecular Diagnostic and Other Direct
    Identification Tests


    List of Tables (continued)
    Major Companies Developing or Marketing Septicemia
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Shigella
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Streptococci
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Syphilis
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Toxoplasmosis
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Trichomonas
    Molecular Diagnostic and Other Direct
    Identification Tests
    Major Companies Developing or Marketing Tuberculosis
    Molecular Diagnostic and Other Direct
    Identification Tests
    Oncogenes Potential Application in Cancer Diagnosis
    Major Companies Developing or Marketing Cancer
    Molecular Diagnostic Tests
    Major Companies Developing or Marketing Molecular
    Diagnostic Tests For Genetic Diseases


    List of Tables (continued)
    U.K.
    Molecular Diagnostics Test Volume And Sales
    By Major Application
    U.K.
    Laboratories Performing DNA Sequencing
    By Market Segment
    U.K.
    Molecular Diagnostics Market
    Potential Laboratory Universe by Market Segment
    U.K.
    Molecular Diagnostics Test Volume
    By Major Application
    U.K.
    Major Infectious Disease Test Volume by Assay
    U.K.
    Major Infectious Disease Test Volume by Method
    U.K.
    Molecular Diagnostics Market
    By Major Application
    U.K.
    Molecular Diagnostics Market
    Estimated Sales And Market Shares of Major Suppliers
    U.K.
    Major Infectious Disease Diagnostics Market by Assay
    U.K.
    AIDS Testing Market
    Estimated Sales by Major Supplier


    List of Tables (continued)
    U.K.
    Gonorrhea Testing Market
    Estimated Sales by Major Supplier
    U.K.
    Hepatitis Testing Market
    Estimated Sales by Major Supplier
    U.K.
    Hepatitis C Testing Market
    Estimated Sales by Major Supplier
    U.K.
    HIV/Hepatitis Blood Screening NAT Market
    Reagent Sales by Major Supplier
    U.K.
    Influenza Testing Market
    Estimated Sales by Major Supplier
    U.K.
    Mycoplasma Testing Market
    Estimated Sales by Major Supplier
    U.K.
    Pneumonia Testing Market
    Estimated Sales by Major Supplier
    U.K.
    Shigella Testing Market
    Estimated Sales by Major Supplier

  • View This Report »

    Get Industry Insights. Simply.

    • Latest reports & slideshows with insights from top research analysts
    • 24 Million searchable statistics with tables, figures & datasets
    • More than 10,000 trusted sources
    24/7 Customer Support

    Talk to Veronica

    +1 718 514 2762

    Purchase Reports From Reputable Market Research Publishers
    2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

    2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

    • $ 54501
    • Industry report
    • October 2016
    • by Venture Planning Group

    This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

    2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

    2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

    • $ 54501
    • Industry report
    • October 2016
    • by Venture Planning Group

    This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

    2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

    2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

    • $ 47500
    • Industry report
    • October 2016
    • by Venture Planning Group

    This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


    ref:plp2015

    Reportlinker.com © Copyright 2016. All rights reserved.

    ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.